Repression of the Wnt-TCF crypt/adenoma signature in patient samples and in xenografts versus in vitro cultures indicated the possibility that Wnt-TCF signaling might be replaced by other signaling pathways during tumor progression, ending in further reprogramming (with immortalization potentially emerging in cells within the same population through a secondary oncogenic pathway). The gene discussed is HNF4A; the disease is neoplasm.